Clinical Trial Update: Hepatocellular Carcinoma - Advanced Stage - Sorafenib Trial in Taiwanese Patients [Phase 4]

View source ↗

Summary

Phase 4 trial of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Bayer | Conditions: Hepatocellular Carcinoma | Phase 4 | Status: COMPLETED